A detailed history of Qsemble Capital Management, LP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Qsemble Capital Management, LP holds 10,743 shares of NBIX stock, worth $1.35 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
10,743
Holding current value
$1.35 Million
% of portfolio
0.23%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$114.58 - $153.15 $1.23 Million - $1.65 Million
10,743 New
10,743 $1.24 Billion

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Qsemble Capital Management, LP Portfolio

Follow Qsemble Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qsemble Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Qsemble Capital Management, LP with notifications on news.